Abstract
Nicotinamide adenine dinucleotide (NAD+) and its related metabolites (NADome) are important endogenous analytes that are thought to play important roles in cellular metabolism, inflammation, oxidative stress, cancer, neurodegeneration, and aging in mammals. However, these analytes are unstable during the collection of biological fluids, which is a major limiting factor for their quantitation. Herein, we describe a highly robust and quantitative method using liquid chromatography coupled to tandem mass spectrometry to quantify the NADome in whole blood, plasma, mononuclear cells, platelets, cerebrospinal fluid (CSF), and urine. This methodology represents a “gold standard” of measure for understanding biological pathways and developing targeted pharmacological interventions to modulate NAD+ biosynthesis and NAD-dependent mediators in health and disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Massudi H, Grant R, Guillemin GJ, Braidy N (2012) NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Rep 17(1):28–46
Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, Grant R (2011) Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One 6(4):e19194. https://doi.org/10.1371/journal.pone.0019194
Braidy N, Poljak A, Grant R, Jayasena T, Mansour H, Chan-Ling T et al (2014) Mapping NAD(+) metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence. Biogerontology 15(2):177–198
Braidy N, Poljak A, Grant R, Jayasena T, Mansour H, Chan-Ling T et al (2015) Differential expression of sirtuins in the aging rat brain. Front Cell Neurosci 9:167. https://doi.org/10.3389/fncel.2015.00167
Braidy N, Berg J, Clement J, Khorshidi F, Poljak A, Jayasena T et al (2018) Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes. Antioxid Redox Signal 30(2):251–294
Trammell SA, Brenner C (2013) Targeted, LCMS-based metabolomics for quantitative measurement of NAD(+) metabolites. Comput Struct Biotechnol J 4:e201301012. https://doi.org/10.5936/csbj.201301012
Clement J, Wong M, Poljak A, Sachdev P, Braidy N (2018) The plasma NAD(+) metabolome is dysregulated in “normal” aging. Rejuvenation Res 22(2):121–130
Seyedsadjadi N, Berg J, Bilgin AA, Braidy N, Salonikas C, Grant R (2018) High protein intake is associated with low plasma NAD+ levels in a healthy human cohort. PLoS One 13(8):e0201968. https://doi.org/10.1371/journal.pone.0201968
Long AN, Owens K, Schlappal AE, Kristian T, Fishman PS, Schuh RA (2015) Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer’s disease-relevant murine model. BMC Neurol 15:19. https://doi.org/10.1186/s12883-015-0272-x
Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW et al (2016) Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 7:12948. https://doi.org/10.1038/ncomms12948
Casabona G, Sturiale L, L’Episcopo MR, Raciti G, Fazzio A, Sarpietro MG et al (1995) HPLC analysis of cyclic adenosine diphosphate ribose and adenosine diphosphate ribose: determination of NAD+ metabolites in hippocampal membranes. Ital J Biochem 44(5):258–268
Bernofsky C, Swan M (1973) An improved cycling assay for nicotinamide adenine dinucleotide. Anal Biochem 53(2):452–458
Acknowledgments
N.B. is the recipient of the Australian Research Council Discovery Early Career Research Award at the University of New South Wales, Sydney, Australia.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Jayasena, T. et al. (2020). Clinical Assessment of the NADome as Biomarkers for Healthy Aging. In: Guest, P. (eds) Clinical and Preclinical Models for Maximizing Healthspan. Methods in Molecular Biology, vol 2138. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0471-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0471-7_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0470-0
Online ISBN: 978-1-0716-0471-7
eBook Packages: Springer Protocols